Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Search Results for 已驗證的CTAL-TTA_Syll19_4.0 考題資源和資格考試領導者和可靠的CTAL-TTA_Syll19_4.0:ISTQB Certified Tester Advanced Level - Technical Test Analyst (V4.0) 🌸 《 www.newdumpspdf.com 》是獲取⮆ CTAL-TTA_Syll19_4.0 ⮄免費下載的最佳網站CTAL-TTA_Syll19_4.0熱門認證

765 posts found

NCCI Reports on Medical Inflation Insights

The National Council on Compensation Insurance (NCCI) published a new Medical Inflation Insights report, which provides a quarterly overview of the latest insights and analysis into what is driving changes...
Read More

WCRI Publishes Medical Price Index

The Workers’ Compensation Research Institute (WCRI) published the 17th edition of their Medical Price Index for Workers’ Compensation, an annual study that compares prices paid for medical professional services across...
Read More

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

...years of age and older, weighing at least 40 kilograms (88 pounds) and should only be administered in a hospital or healthcare setting capable of providing acute care comparable to...
Read More

New National Substance Abuse Report

...and relevant behaviors, attitudes, and other factors. At nearly 200 pages, there is a wide range of insights available in the latest report, but focusing on midlife adults, there are...
Read More

WCRI Publishes Medical Price Index

The Workers’ Compensation Research Institute (WCRI) published the 17th edition of their Medical Price Index for Workers’ Compensation, an annual study that compares prices paid for medical professional services across...
Read More

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

...bills that failed to pass in 2024; A4371 and S1943. For ongoing coverage of the latest legislation and policy updates impacting workers' comp, visit the Healthesystems Advocacy & Compliance page for our weekly Regulatory Recap....
Read More

FDA Considers Policy Changes for GLP-1 Compounds

...common comorbidity in the U.S. population. With many of these drugs experiencing shortages, compounders in the last few years have created their own formulations of these medications to meet demands....
Read More

Recalls and Alerts Impacting Workers’ Comp

...drug. The FDA encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose of compounded semaglutide. Many of the patients...
Read More

Department of Justice Reaches $21.5 Million Settlement Over Inflated AWP for Compound Ingredients

...two ingredients used in compound prescriptions. According to the DOJ, Medisca acquired resveratrol from manufacturers for approximately $0.37 per gram, then repackaged and sold it for under $2.00 per gram....
Read More

California P&T Committee Outlines Pharmacy Topics for Review

...these medications being intended for short-term therapy. Committee members raised concerns that prolonged PPI use could contribute to preventable comorbidities and increase downstream medical costs if not appropriately managed. Although...
Read More

4 Ways to Manage Medical Supply Chain Disruption in Workers’ Comp

With the healthcare supply chain experiencing a multitude of disruptions, delays, shortages, and other concerns, an undeniable impact has been made on the delivery of workers’ comp products and services,...
Read More

The Impact of Adverse Weather on Workers’ Comp Claims

The National Council on Compensation Insurance (NCCI) published a new report on Adverse Weather and Workers’ Compensation Claims, analyzing NCCI data from 35 states from 2001-2022 to examine the link...
Read More

FDA Approves New Formulation of Combogesic

...adjunct to opioid analgesics. Combogesic should be limited to five days of use or less. Combogesic features similar warnings that respectively come with acetaminophen and ibuprofen products. Acetaminophen can be...
Read More

California P&T Committee Reviews Rising Drug Costs and Utilization Patterns

The California Division of Workers’ Compensation’s (DWC) Pharmacy & Therapeutics Committee meeting took place on July 15th, and Healthesystems attended this meeting to monitor emerging formulary, utilization, and drug-spend trends....
Read More

Tipping the Scales? GLP-1 Considerations for Workers’ Comp

...comp industry is still emerging, early indicators point to limited utilization with disproportionate financial impact. The Workers Compensation Research Institute (WCRI) reports that GLP-1s are appearing in a small number...
Read More
1 2 3 4 5 … 22 23 24 25 26 … 47 48 49 50 51
lockmap-markermagnifiercrossmenuarrow-rightcross-circle